Medicare Part D coverage · tazarotene · RxCUI 1293451
tazarotene 1 MG/ML Topical Foam
Per the CMS 2026 Part D formulary file, tazarotene 1 MG/ML Topical Foam is covered by 22 Medicare Part D plans (0.4% of enrollable products), averaging Tier 3.3, with prior authorization required on 75% of covering formularies.
- 0.4%
- Plan coverage
- 22
- Plans covering
- T3.3
- Avg tier
- 75%
- Prior auth required
What the CMS Formulary Data Shows for tazarotene 1 MG/ML Topical Foam
Per the CMS 2026 Part D formulary file, tazarotene 1 MG/ML Topical Foam (RxNorm concept RXCUI 1293451, generic name tazarotene) appears on 4 distinct formulary files spanning 22 Medicare Part D plan offerings - 0.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.3.
Real-world access to tazarotene 1 MG/ML Topical Foam depends on utilization management as much as tier placement: 75% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,869 Part D beneficiaries filled tazarotene 1 MG/ML Topical Foam in 2023, with total plan-and-beneficiary spending of $2,710,202 and an average per-beneficiary annual cost of $556.62. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tazarotene 1 MG/ML Topical Foam today.
Coverage Details
- Formularies covering
- 4
- Plans covering
- 22
- Coverage rate
- 0.4%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 75% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,869
- Total spending
- $2,710,202
- Avg per beneficiary
- $556.62
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering tazarotene 1 MG/ML Topical Foam
22 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T4 | Yes | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T4 | Yes | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T4 | Yes | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | Yes | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | Yes | $0 | NY |
| CDPHP $0 Medicare Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | Yes | $0 | NY |
| Univera SeniorChoice Core (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $33.00 | NY |
| Univera SeniorChoice Advanced (HMO-POS) | Excellus Health Plan, Inc. | T4 | Yes | $36.90 | NY |
| Medicare BlueClassic (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $51.00 | NY |
| Univera SeniorChoice Secure (HMO-POS) | Excellus Health Plan, Inc. | T4 | Yes | $54.90 | NY |
| Medicare BlueBalanced (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $55.00 | NY |
| Medicare Blue Choice Prime (HMO) | Excellus Health Plan, Inc. | T4 | Yes | $55.00 | NY |
| Univera SeniorChoice Value Plus (HMO-POS) | Excellus Health Plan, Inc. | T4 | Yes | $58.60 | NY |
| Medicare BlueEnhanced (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $70.30 | NY |
| Medicare BluePlus (PPO) | Excellus Health Plan, Inc. | T4 | Yes | $86.40 | NY |
| CDPHP Clear Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | Yes | $100.00 | NY |
Show the next 2 plans
| CDPHP Choice Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | Yes | $135.00 | NY |
| Medicare Blue Choice Optimum (HMO-POS) | Excellus Health Plan, Inc. | T4 | Yes | $146.00 | NY |
Frequently Asked Questions
Is tazarotene 1 MG/ML Topical Foam covered by Medicare Part D?
Yes, tazarotene 1 MG/ML Topical Foam is covered by 22 Medicare Part D plans (0.4% of all Part D formularies).
What tier is tazarotene 1 MG/ML Topical Foam on Medicare Part D plans?
tazarotene 1 MG/ML Topical Foam averages Tier 3.3 across Part D plans, ranging from Tier 1 to Tier 4.
Does tazarotene 1 MG/ML Topical Foam require prior authorization?
75% of Part D formularies require prior authorization for tazarotene 1 MG/ML Topical Foam. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on tazarotene 1 MG/ML Topical Foam?
In 2023, total Medicare Part D spending on tazarotene 1 MG/ML Topical Foam was $2,710,202, covering 4,869 beneficiaries. The average spend per beneficiary was $556.62.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] T3.3
- 0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe T3.3
- Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet T3.3
- prednisolone 10 MG Disintegrating Oral Tablet [Orapred] T3.3
- molindone hydrochloride 5 MG Oral Tablet T3.2
- degarelix 80 MG Injection [Firmagon] T3.2
Similar prior-authorization rate
- 0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector 75% PA
- cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia] 75% PA
- carbinoxamine maleate 0.8 MG/ML Oral Solution 75% PA
- sepiapterin 1000 MG Oral Powder [Sephience] 75% PA
- 1 ML octreotide 0.5 MG/ML Injection 75% PA
- vigabatrin 100 MG/ML Oral Solution [Vigafyde] 75.1% PA